In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Dravet syndrome is a rare and refractory epileptic encephalopathy, and Stiripent···【more】
Release date:2024-08-28Recommended:315
Stiripentol is an innovative antiepileptic drug used to treat Dravet syndrome, m···【more】
Release date:2024-08-28Recommended:287
Fidaxomicin is a white to off-white film-coated oblong tablet and should be used···【more】
Release date:2024-08-28Recommended:313
Fidaxomicin works by inhibiting the RNA polymerase of bacteria, which has little···【more】
Release date:2024-08-28Recommended:342
Fidaxomicin is a macrolide antibiotic developed by Optimer and approved by the F···【more】
Release date:2024-08-28Recommended:410
Balversa is specifically designed for patients with advanced urothelial carcinom···【more】
Release date:2024-08-28Recommended:308
Balversa is a targeted drug targeting FGFR mutations for the treatment of advanc···【more】
Release date:2024-08-28Recommended:385
Balversais an oral anti-tumor drug for the treatment of urothelial carcinoma wit···【more】
Release date:2024-08-28Recommended:297
Balversa is a new anti-cancer drug targeting FGFR, targeting urothelial carcinom···【more】
Release date:2024-08-28Recommended:334
Balversais an oral anti-cancer drug mainly used for the treatment of advanced or···【more】
Release date:2024-08-28Recommended:412
Balversais an anti-tumor drug for FGFR mutant tumors, which is usually administe···【more】
Release date:2024-08-27Recommended:341
Balversa is an innovative targeted therapy drug that is clinically used in patie···【more】
Release date:2024-08-27Recommended:319